DocGo Inc. reports developments in technology-enabled mobile health, medical transportation, remote patient monitoring and virtual care. The company’s care delivery platform combines in-home or workplace treatment with remote physicians, a 50-state virtual care network and integrated Ambulnz medical transport services.
Recurring news themes include quarterly and annual results, revenue guidance, customer expansions, EMS hiring and efficiency initiatives, investor conference presentations, governance and compliance recognition, and activity at SteadyMD, DocGo’s virtual care division. Company updates also describe demand for clinician-led telehealth programs, including branded GLP-1 weight loss care support.
DocGo (Nasdaq: DCGO) reported third-quarter 2026 revenue of $73.4 million and began searching for a successor to CEO Lee Bienstock. Revenue rose from $70.8 million a year earlier. GAAP gross margin increased to 29.7% from 20.0%, while the consolidated net loss narrowed to $18.3 million from $29.7 million.
DocGo expects full-year revenue of approximately $300 million, down from $305–$310 million, reflecting elimination and restructuring of unprofitable businesses. Its adjusted EBITDA outlook, a non-GAAP earnings measure, remains a loss of $17–$22 million. Unrestricted cash fell to $19.1 million from $25.2 million at June 30, before October 1 debt funding from Perceptive Advisors. The Hicuity Health acquisition is expected to close in late November or early December. Bienstock's contract expires December 31; he will continue as CEO until a successor is appointed and remain through at least March 31, 2027.
DocGo (Nasdaq: DCGO) will release its third-quarter 2026 financial results after markets close on Monday, November 9, 2026. The results cover the quarter ended September 30, 2026. Management will host a conference call and webcast to discuss the results at 5:00 p.m. ET that day.
DocGo (DCGO) will host a live webinar on Tuesday, September 29, 2026, at 11:00 a.m. ET to discuss its pending acquisition of Hicuity Health.
The event will feature DocGo Chief Executive Officer Lee Bienstock alongside senior Hicuity Health executives, who will outline the vision and details for combining DocGo’s mobile health and medical transportation platform with Hicuity’s tele-ICU, virtual nursing, telemetry monitoring and other virtual care services for hospitals and health systems.
Investors and other interested parties can join the webcast at https://viavid.webcasts.com/starthere.jsp?ei=1776768&tp_key=ed365007d2 or via the Events section of DocGo’s investor relations website, where presentation materials will be posted immediately before the call.
DocGo (Nasdaq: DCGO) announced that CEO Lee Bienstock will attend the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16. He will hold 1x1 investor meetings and give a fireside presentation at 12:20 PM ET, with a live webcast available via DocGo’s investor relations website.
DocGo (Nasdaq: DCGO) reported second quarter 2026 revenue of $73.4 million, down from $80.4 million a year earlier, with the decline attributed entirely to the wind-down of migrant-related programs. Excluding these programs, revenue grew 19% year over year. GAAP gross margin was 26.9%, and net loss was approximately $18.0 million, while adjusted EBITDA was a loss of $6.3 million.
The company signed a definitive agreement to acquire virtual care provider Hicuity Health, which generated about $65 million in trailing 12‑month revenue and $4.5 million of adjusted EBITDA. DocGo will assume approximately $52 million of Hicuity debt held by Perceptive Advisors, and Hicuity’s preferred shareholder will receive equity equal to about 2% of DocGo’s current shares plus up to an additional 3.5% contingent on future market capitalization. Perceptive Advisors also committed to provide up to $50 million in additional debt financing. DocGo narrowed 2026 revenue guidance to $305–$310 million and reduced adjusted EBITDA guidance to a loss of $17–$22 million, while reiterating expectations to exit 2026 at a profitable adjusted EBITDA run rate.
DocGo (Nasdaq: DCGO) will release its financial results for the second quarter ended June 30, 2026, after U.S. markets close on Monday, August 17, 2026. Management will host a conference call and webcast at 5:00 p.m. ET the same day to discuss the results.
Investors can join via phone at 1-800-717-1738 (U.S.) or 1-646-307-1865 (international) using Conference ID 78516, or access a live webcast under the Events section of DocGo’s investor relations website.
DocGo (Nasdaq: DCGO) announced that subsidiary PTI Health by DocGo has launched mobile phlebotomy services in Southern Florida and expanded its relationship with a major national clinical laboratory across the Southeast.
The business uses a low capital investment model and targets Florida’s large older adult population with at-home blood collection and testing, leveraging existing partner ordering platform integrations as part of DocGo’s broader “healthcare at any address” strategy.
DocGo (Nasdaq: DCGO) announced that CEO Lee Bienstock will join a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, from 3:20–3:55 PM Eastern Time.
A live webcast will be accessible via DocGo’s investor relations website.
DocGo (Nasdaq: DCGO) reported Q1 2026 revenue of $75.6 million, down from $96.0 million due to the wind-down of migrant-related programs. Excluding those programs, revenue rose 19.3% year-over-year.
Net loss was $16.7 million and adjusted EBITDA was ($10.2) million. 2026 revenue guidance increased to $300–$315 million, with adjusted EBITDA expected at ($5)–($10) million. Mobile Health revenue excluding migrant programs grew 131%, healthcare-at-any-address revenue rose 36% sequentially, and DocGo highlighted strong volume growth across major service lines.
DocGo (Nasdaq: DCGO) announced that CEO Lee Bienstock will present at the 21st Annual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, from 11:45–12:25 PM ET. The presentation will include 1x1 meetings and a live webcast.
A webcast will be available on DocGo's investor relations website.